在轻度高皮质醇症患者中, metyrapone 的作用
Antonio Musolino1, Vittoria Favero1,2, Chiara Parazzoli1,2
1Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan 20100, Italy.
European journal of endocrinology
|October 16, 2025
概括
低剂量的晚上 metyrapone 改善了轻度高皮质醇症 (mH) 患者的血压 (BP). 这种安全的治疗方法也对葡萄糖代谢有好处,特别是在2型糖尿病患者中.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 轻度高皮质醇 (mH) 呈现微妙的迹象,但会增加心脏代谢风险.
- 目前对mH的治疗包括手术,对于非手术候选人的医疗选择.
- 有限的数据存在于药物治疗的疗效,特别是血压 (BP) 控制在mH.
研究的目的:
- 评估低剂量晚上甲基拉对24小时门诊血压的影响.
- 评估对mH患者葡萄糖代谢和皮质醇昼夜节律的影响.
- 为了确定 metyrapone 的安全性和有效性,用于 mH 管理.
主要方法:
- 对20名mH患者进行前性,单中心的观察性研究.
- 治疗包括24周的晚上 metyrapone (250-500 毫克/天).
- 评估包括血压,葡萄糖代谢和唾液皮质醇在基线和随访.
主要成果:
- 40%的患者实现了临床显著的血压降低 (缩≥5mmHg).
- 在基线较高的缩血压患者中,改善更为显著.
- 4名患者的葡萄糖代谢控制得到改善,其中包括2名2型糖尿病患者 (HbA1c降低≥0.5%).
结论:
- 低剂量晚上甲基拉是一种安全和潜在的有效选择,用于mH.
- 它有望改善血压控制,特别是在高血压的mH患者中.
- 进一步的研究可能会探索其在管理mH代谢障碍中的作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
429
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
429
Adrenal Gland Disorders
2.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
483
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
483
COPD: Management Using Bronchodilators and Corticosteroids
722
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
722
Hypoglycemia and Glucagon
826
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
826
Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806


